Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
The MHRA's marketing authorization of Oczyesa is based on the results from a comprehensive clinical program comprising seven clinical studies, including two Phase 3 studies within the ACROINNOVA program. The MHRA's marketing authorization of Oczyesa is based on the results from a comprehensive clinical program comprising seven clinical studies, including two Phase 3 studies within the ACROINNOVA program. Oczyesa is formulated using Camurus' proprietary FluidCrystal ®technology. The product...
PR Newswire
28/08/2025
Home Textile Market to Reach $192.8B by 2029 | Bedding & Curtains Drive Growth -…
How the Home Textile Market Growth Benefits You? Download Free Home Textile Market Sample Report What are the key factors driving the growth of the Home textile market? Source from Valuates Reports on Home textile market TRENDS INFLUENCING THE GROWTH OF THE HOME TEXTILE MARKET: Bedding plays a crucial role in driving the home textile market by blending comfort, aesthetics, and wellness into one cohesive consumer experience. Modern households view bedding...
PR Newswire
28/08/2025
Orthopedic Braces & Supports Market worth US$5.5 billion by 2030 with 6.5% CAGR…
Browse in-depth TOC on "Orthopedic Braces & Supports Market" Browse in-depth TOC on "Orthopedic Braces & Supports Market" 350 - Tables 50 - Figures 310 - Pages By product,the orthopedic braces & supports market is segmented into knee braces & supports, ankle braces & supports, foot walkers & orthoses, back, hip and spine braces & supports (neck and cervical, lower spine), shoulder braces & supports, elbow braces & supports, hand &…
PR Newswire
28/08/2025
Unlocking the Power of Nutrition: Purina Institute Releases New Well-Pet…
A follow-up to the Purina Institute Handbook of Canine and Feline Clinical Nutrition that was introduced in 2023, the Handbook of Canine and Feline Well-Pet Nutrition addresses the many questions and challenges faced by veterinary professionals in discussing nutrition with clients. Information covers essential topics, such as: A follow-up to the Purina Institute Handbook of Canine and Feline Clinical Nutrition that was introduced in 2023, the Handbook of Canine and Feline Well-Pet Nutrition...
PR Newswire
28/08/2025
Heading: Oncology Therapy Market Size worth US$ 440.26 Billion by 2033, Boasting…
Market momentum is further amplified by high-value partnerships, such as Bristol Myers Squibb's $11.1 billion deal with BioNTech, signaling sustained investor confidence in immunotherapies as future growth engines and Boehringer Ingelheim's FDA approval for Hernexeos in lung cancer underscores how both established and emerging players are intensifying innovation pipelines to capture market share. Together, these dynamics highlight a sector at an inflection point—one where oncology therapies are…
PR Newswire
28/08/2025
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market…
VANCOUVER, BC, Aug. 28, 2025 /PRNewswire/ -- Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with oncology ventures securing hundreds of millions in funding so far in 2025. The Senate's recent restoration of $15 million for the Pancreatic Cancer Research Program (PCARP) was a win, yet its earlier elimination underscored the fragility of public support. Against this backdrop, investors are zeroing in on…
PR Newswire
28/08/2025
Life Science Tools Market to Grow at a CAGR of 10.81% from 2025 to 2032 |…
Get a free sample report - https://www.skyquestt.com/sample-request/life-science-tool-market Get a free sample report -https://www.skyquestt.com/sample-request/life-science-tool-market The life science tools market is experiencing robust growth, primarily driven by increased investments in biomedical research, the expansion of biotechnology and pharmaceutical industries, and rising demand for personalized medicine and genomics-based diagnostics. The surge in chronic diseases, infectious...
PR Newswire
28/08/2025
Surgical Imaging Market worth US$12.2 billion by 2030 with 17.6% CAGR |…
Browse in-depth TOC on "Surgical Imaging Market" Browse in-depth TOC on "Surgical Imaging Market" 400 - Tables 50 - Figures 400 - Pages By product,the surgical imaging market is divided into C-arm systems, CT scanners, ultrasound systems, integrated MR-OR systems, surgical navigation systems, and accessories. C-arms hold the largest market share, mainly because of their widespread use across various surgical specialties, including orthopedics, cardiovascular, and trauma...
PR Newswire
28/08/2025
Cancer Diagnostics Market to Grow at a CAGR of 9.4% from 2025 to 2032 | SkyQuest…
Get a Free Sample Report: https://www.skyquestt.com/sample-request/cancer-diagnostics-market Get a Free Sample Report: https://www.skyquestt.com/sample-request/cancer-diagnostics-market Cancer Diagnostics Market Key Growth Drivers The cancer diagnostics market has experienced significant growth owing to growing demand for point-of-care cancer diagnostics, particularly in developing regions with limited access to centralized healthcare. These portable, user-friendly tools enable...
PR Newswire
28/08/2025
Wound Dressings Market worth US$15.87 billion by 2030 with 6.5% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=123903496 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=123903496 Browse in-depth TOC on "Wound Dressings Market" 394 - Tables 50 - Figures 352 - Pages By type,the wound dressings market is divided into traditional wound dressings and advanced wound dressings. In 2024, the advanced wound dressings segment held the largest market share. This dominance is...
PR Newswire
28/08/2025
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide…
Generic Saxenda ®is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.This approval and launch add to Teva’s continued commitment to its complex generic medicine portfolio as part of its Pivot to Growth Strategy.Liraglutide injection is indicated for adults with obesity or overweight (excess weight) who also have weight related medical problems, and pediatric patients (12-17 years) with a weight...
Nasdaq GlobeNewswire
28/08/2025
Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to…
CRO Revenue Returned to Positive Growth CRO Revenue Returned to Positive Growth During the Reporting Period, the Company's revenue from CRO business amounted toRMB 422.8 million, representing a year-over-year increase of approximately 9.6%, and the adjusted gross profit amounted toRMB194.6 million, representing a year-over-year increase of approximately 16.4%. The growth in CRO revenue during the first half of 2025 was primarily attributable to the recovery in global...
PR Newswire
28/08/2025
SKF's Capital Markets Day to be held on 11 November 2025
In addition, financial targets for the SKF Group post separation of the Automotive, i.e. the Industrial business, will be presented at the event. For the Automotive business, indicative financial objectives will be shared. In addition, financial targets for the SKF Group post separation of the Automotive, i.e. the Industrial business, will be presented at the event. For the Automotive business, indicative financial objectives will be shared. "We look forward to meet investors, analysts…
PR Newswire
28/08/2025
New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to…
"Reader studies have long been a gold standard across medicine to validate diagnostic technologies in real-world settings," said Dr. Alexander Meves, Department of Dermatology, Mayo Clinic. "Our findings show that Nevisense brings measurable improvements in diagnostic accuracy, providing dermatologists with a reliable adjunct to dermoscopy in the evaluation of melanoma. With the rapid development of augmented intelligence (AuI)-based technologies and novel diagnostic tools, reader…
PR Newswire
28/08/2025
SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI…
Sonrai's cloud-based AI platform for precision medicine empowers biotech and pharmaceutical teams to streamline diagnostic workflows, enhance molecular profiling and accelerate biomarker discovery, by integrating imaging and omics data, within a secure data ecosystem. By embedding these unique capabilities into SmartLabs' five managed research centers, member companies will gain access not only to the Sonrai Discovery platform, but also to exclusive informatics and AI applications available only…
PR Newswire
28/08/2025
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply…
Tilray Affirms Continued Commitment to German Healthcare and Expanding Patient and Pharmacy Access in Europe's Largest Medical Cannabis Market LONDON and NEUMÜNSTER, Germany, Aug.28, 2025(GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming...
Nasdaq GlobeNewswire
28/08/2025
AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025
AAVantgarde Bio(AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated LUCE-1 clinical data at the25th European Society of Retina Specialists (EURETINA) Annual Congress (EURetina 2025), taking place in Paris 4-7 September 2025. AAVantgarde will also be presenting at the Ophthalmology Futures Forum (OFF) and EURetina Innovation Spotlight (EIS) events on the 3 rdSeptember...
Nasdaq GlobeNewswire
28/08/2025
Amendment: Trading by management and close relations of management
Please read the announcement in PDF Attachment 2025_42_Trading_By_Management
Nasdaq GlobeNewswire
28/08/2025
KFSHRC Advances Nursing Excellence Through Specialized Training
Specialized diplomas and internships shape future leaders The Nurse Practitioner Clinic has widened access to specialized care while integrating advanced practice nurses into critical diagnostic and treatment workflows. Similarly, the VTE Prevention Program uses real-time digital dashboards to monitor risk, improve documentation, and escalate issues promptly,contributing to safer outcomes across care settings.To standardize high-impact practice, KFSHRC delivers immersive training through...
Nasdaq GlobeNewswire
28/08/2025
Sai Life Sciences completes Phase II of Production Block 11 at Bidar site…
Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV).The Phase I of PB-11, with a capacity of 110 KL, was inaugurated in December 2024. With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL, making it the single largest reactor volume block at the Bidar site...
Nasdaq GlobeNewswire
28/08/2025
Esaote Group to Showcase Cardiac Innovation at ESC 2025 in Madrid
Among the highlights will be the launch of the MyLab™C30* cardio, a powerful portable ultrasound system engineered specifically for cardiology. With the largest-in-class touchscreen, an intuitive touch interface, and advanced AI-powered tools, the MyLab™C30 cardio significantly reduces examination time while ensuring diagnostic confidence—even in the most complex cases, by providing reliable qualitative and quantitative assessments. Its extended battery life and robust performance make it ideal…
PR Newswire
28/08/2025
Trading by management and close relations of management
Please read the announcement in PDF Attachment 2025_41_Trading_By_Management
Nasdaq GlobeNewswire
28/08/2025
Oculis to Participate in Upcoming September Investor Conferences
/ XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in upcoming investor conferences in September. Wells Fargo Healthcare ConferenceSeptember 3-5; Boston, U.S. Riad Sherif, M.D., Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer, will attend.H.C. Wainwright 27th Annual Global...
Nasdaq GlobeNewswire
28/08/2025
Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare…
Leucid Bio is a privately-held biotechnology company dedicated to the development of cell therapies for the treatment of solid tumours using the Company's proprietary lateral CAR platform. The Company's lead asset, LEU011, is an autologous CAR-T cell therapy targeting NKG2D ligands, which are expressed on more than 80% of human tumours. In addition, LEU011 co-expresses the chemokine receptor CXCR2 which is engineered to enhance cell trafficking and tumour infiltration. For more information…
PR Newswire
28/08/2025
Altri Comunicati
